Search results
Results from the WOW.Com Content Network
AstraZeneca plc ( / ˌæstrəˈzɛnəkə /) ( AZ) is a British-Swedish multinational pharmaceutical and biotechnology company [ 2][ 3][ 4] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. [ 5] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection ...
1. 2015. Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [ 12][ 13] Had this transaction been completed, this would have been the largest within this industry.
Website. www.medimmune.com [dead link] MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. [ 1][ 2] MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion. [ 3]
If AstraZeneca (AZN) and Gilead (GILD) were to combine into one, it would be the biggest health-care deal ever. AstraZeneca Reportedly Approaches Gilead for Potential Merger Skip to main content
A huge merger may be brewing in the drug industry. Pfizer (PFE) reportedly has approached British rival AstraZeneca (AZN) about a takeover. Britain's Sunday Times says the deal could be worth $100 ...
Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases . Its products include eculizumab (Soliris) and ravulizumab (Ultomiris), both used to treat the rare disorders of atypical hemolytic uremic syndrome (aHUS) and ...
AstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by the expected launch of 20 new medicines and through growth in its cancer, biopharmaceuticals ...
Astra AB. Astra AB was a former international pharmaceutical company headquartered in Södertälje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca. [ 1] Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control.